Target intelligence / Profile preview

MT-ND3 pseudogene 4 (MTND3P4)

Target
MTND3P4
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND3 pseudogene 4 (MTND3P4) is a **pseudogene**, meaning it represents a non-functional genomic DNA sequence related to the functional MT-ND3 gene. MT-ND3 is a mitochondrial gene encoding a core protein subunit of NADH:ubiquinone oxidoreductase (Complex I) in the electron transport chain, which is involved in mitochondrial energy production[1][2]. However, MTND3P4 does not produce a functional protein, nor does it participate in cellular energy generation or serve as a drug target[3]. Pseudogenes like MTND3P4 may arise from gene duplication or retrotransposition events and often lack coding potential due to mutations or regulatory differences. There is no evidence that MTND3P4 has canonical biological, biochemical, or disease roles; information about function, druggability, biomarkers, or safety does not apply[3]. **Important note:** Information about disease or pharmacology for MT-ND3 (the functional gene) should not be conflated with MT-ND3 pseudogene 4, as only the active MT-ND3 gene is associated with mitochondrial disease and energy metabolism. Pseudogenes generally do not encode proteins and are not considered molecular targets. **Key distinctions:** - MT-ND3 (functional gene) is involved in mitochondrial function and disease; MTND3P4 is a non-coding pseudogene. - MTND3P4 is not a receptor, enzyme, transporter, or any canonical drug target[3]. If you need information about the functional MT-ND3 gene (not the pseudogene), please clarify, as the biological and therapeutic information will be distinct[1][2][4].

Other names
MTND3P4MT-ND3 Pseudogene 4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 pseudogene 4

Beyond the preview

Go deeper on MT-ND3 pseudogene 4 (MTND3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND3 pseudogene 4 (MTND3P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call